Kikushima, W.; Sakurada, Y.; Sugiyama, A.; Yoneyama, S.; Matsubara, M.; Fukuda, Y.; Kashiwagi, K.
Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity. J. Clin. Med. 2021, 10, 1098.
https://doi.org/10.3390/jcm10051098
AMA Style
Kikushima W, Sakurada Y, Sugiyama A, Yoneyama S, Matsubara M, Fukuda Y, Kashiwagi K.
Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity. Journal of Clinical Medicine. 2021; 10(5):1098.
https://doi.org/10.3390/jcm10051098
Chicago/Turabian Style
Kikushima, Wataru, Yoichi Sakurada, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, and Kenji Kashiwagi.
2021. "Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity" Journal of Clinical Medicine 10, no. 5: 1098.
https://doi.org/10.3390/jcm10051098
APA Style
Kikushima, W., Sakurada, Y., Sugiyama, A., Yoneyama, S., Matsubara, M., Fukuda, Y., & Kashiwagi, K.
(2021). Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity. Journal of Clinical Medicine, 10(5), 1098.
https://doi.org/10.3390/jcm10051098